$2.31T
Total marketcap
$107.57B
Total volume
BTC 49.93%     ETH 15.50%
Dominance

KOREA PHARMA Co., Ltd. 032300.KQ Stock

19890 KRW {{ price }} -2.503682% {{change_pct}}%
Exchange
KOSDAQ
Market Cap
216.93B KRW
LOW - HIGH [24H]
19780 - 20350 KRW
VOLUME [24H]
26.85K KRW
{{ volume }}
P/E Ratio
0
Earnings per share
0 KRW

KOREA PHARMA Co., Ltd. Price Chart

KOREA PHARMA Co., Ltd. 032300.KQ Financial and Trading Overview

KOREA PHARMA Co., Ltd. stock price 19890 KRW
Previous Close 19510 KRW
Open 19610 KRW
Bid 19660 KRW x N/A
Ask 19670 KRW x N/A
Day's Range 19430 - 19710 KRW
52 Week Range 19280 - 44000 KRW
Volume 8.77K KRW
Avg. Volume 30.92K KRW
Market Cap N/A
Beta (5Y Monthly) 1.683363
PE Ratio (TTM) N/A
EPS (TTM) 0 KRW
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

032300.KQ Valuation Measures

Enterprise Value 221.86B KRW
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) N/A
Enterprise Value/Revenue 2.722
Enterprise Value/EBITDA 25.839

Trading Information

KOREA PHARMA Co., Ltd. Stock Price History

Beta (5Y Monthly) 1.683363
52-Week Change -22.57%
S&P500 52-Week Change 20.43%
52 Week High 44000 KRW
52 Week Low 19280 KRW
50-Day Moving Average 20306.4 KRW
200-Day Moving Average 22486.85 KRW

032300.KQ Share Statistics

Avg. Volume (3 month) 30.92K KRW
Avg. Daily Volume (10-Days) 14.54K KRW
Shares Outstanding N/A
Float 3.63M
Short Ratio N/A
% Held by Insiders 65.29%
% Held by Institutions 0.20%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate N/A
Trailing Annual Dividend Yield N/A
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2021
Most Recent Quarter (mrq) September 30, 2022
Next Fiscal Year End December 31, 2022

Profitability

Profit Margin 4.35%
Operating Margin (ttm) 7.51%
Gross Margin 43.34%
EBITDA Margin 10.53%

Management Effectiveness

Return on Assets (ttm) 3.61%
Return on Equity (ttm) 6.45%

Income Statement

Revenue (ttm) 81.51B KRW
Revenue Per Share (ttm) 7470.35 KRW
Quarterly Revenue Growth (yoy) 6.00%
Gross Profit (ttm) 35.9B KRW
EBITDA 8.59B KRW
Net Income Avi to Common (ttm) 3.55B KRW
Diluted EPS (ttm) N/A
Quarterly Earnings Growth (yoy) -55.90%

Balance Sheet

Total Cash (mrq) 63.49B KRW
Total Cash Per Share (mrq) 5821.01 KRW
Total Debt (mrq) 53.03B KRW
Total Debt/Equity (mrq) 89.97 KRW
Current Ratio (mrq) 4.348
Book Value Per Share (mrq) N/A

Cash Flow Statement

Operating Cash Flow (ttm) 9.86B KRW
Levered Free Cash Flow (ttm) 1.62B KRW

Profile of KOREA PHARMA Co., Ltd.

Country South Korea
State N/A
City Seoul
Address 14, Teheran-ro 4-gil
ZIP 445 922
Phone 82 558 1277
Website https://www.koreapharma.co.kr
Industry
Sector(s)
Full Time Employees N/A

Korea Pharmacy Co., Ltd. produces pharmaceutical drugs. It offers amino acid, antibiotic, antidotal, antiepileptic, antihistamine, anti-inflammatory, antimicrobial, antiplatelet, circulatory system, CNS, dermatological, endocrine, gastrointestinal, hepatic, hormonal, respiratory, sympathomimetic, and specialty drugs, as well as multivitamins, skeltal muscle relaxants, vitamin B1, etc. The company was founded in 1974 and is based in Seoul, South Korea.

Q&A For KOREA PHARMA Co., Ltd. Stock

What is a current 032300.KQ stock price?

KOREA PHARMA Co., Ltd. 032300.KQ stock price today per share is 19890 KRW.

How to purchase KOREA PHARMA Co., Ltd. stock?

You can buy 032300.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for KOREA PHARMA Co., Ltd.?

The stock symbol or ticker of KOREA PHARMA Co., Ltd. is 032300.KQ.

How many shares does KOREA PHARMA Co., Ltd. have in circulation?

The max supply of KOREA PHARMA Co., Ltd. shares is 10.91M.

What is KOREA PHARMA Co., Ltd. Price to Earnings Ratio (PE Ratio)?

KOREA PHARMA Co., Ltd. PE Ratio is now.

What was KOREA PHARMA Co., Ltd. earnings per share over the trailing 12 months (TTM)?

KOREA PHARMA Co., Ltd. EPS is 0 KRW over the trailing 12 months.